Eterna Therapeutics Income Tax

Eterna Therapeutics (ERNA) currently reports a income tax of $-88K as of June 2026. That compares with $-12K in the prior-year period — down 633.3% year over year. Use the charts on this page to explore Eterna Therapeutics's income tax history and peer comparisons.

Eterna Therapeutics's income tax decreased from $-12K to $-88K — a 633.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Eterna Therapeutics reported $-88K in income tax as of June 2026. That compares with $-12K in the prior-year period — down 633.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current income tax of $-88K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eterna Therapeutics, and consider following ERNA for alerts when major investors trade the stock.

Eterna Therapeutics is classified in the Telecommunications sector. On income tax, it currently shows $-88K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Telecommunications are usually more informative than comparing ERNA with unrelated industries.